| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.50B | +39.4% |
| Gross profit | ¥0.21B | — |
| Operating income | ¥0.07B | — |
| Net income | ¥0.07B | +46.8% |
| Gross margin | 42.8% | Net margin 13.2% |
| Revenue Q/Q | +15.8% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.28B | 57.2% |
| R&D | ¥0.02B | 4.9% |
| SG&A | ¥0.12B | 24.6% |
| Tax & other | ¥0.01B | 1.8% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
莱美药业 ・ 汉威科技 ・ 天海防务 ・ 安科生物 ・ ST豆神 ・ 鼎汉技术 ・ 华测检测 ・ 新宁物流 ・ 北陆药业 ・ 网宿科技 ・ 中元股份 ・ 硅宝科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies